EU Approves AstraZeneca’s Klygefa
The EU approved AstraZeneca’s Klygefa (gefurulimab).
Story updates
07:01:38 AM UTC
SquawkNews
... AstraZeneca Approval based on PREVAIL Phase III trial demonstrating statistically significant an
07:19:18 AM UTC
SquawkNews
By Adam WhittakerAstraZeneca's autoimmune drug Klygefa has been approved in the U.S. and the European Union to treat adults with generalized myasthenia gravis.In separate releases Monday, the U.K. pharmaceutical company said the approvals follow Phase 3 trials that showed the drug delivered a signi…